Thorne claims first NSF Certified for Sport milestone for prenatal with bioactive folate
The company said the certification adds banned substance screening to its existing quality assurance program while leaving the…
The 7-Step Ladder a Professor Uses to Hit Financial Independence
Miguel Marquez has spent years making complex subjects easier to understand. Originally from Spain, the 47-year-old earned a…
Prince William and Princess Kate release new image of Prince George to celebrate his 13th birthday
A new photograph of Prince George has been released by Kensington Palace to mark the royal’s 13th birthday.…
Where Winds Meet makes $22.1m on mobile in six months outside China
Where Winds Meet has made almost $100m since global launch, though China already had access. Outside China, the…
5-MTHF matches folic acid while lowering unmetabolized folic acid in prenatal vitamins
A recent U.S. randomized controlled trial reports that prenatal multivitamins formulated with 5-methyltetrahydrofolate (5-MTHF) can maintain maternal and…
Starlink Hits 10,000 Satellites, SpaceX Now Owns 67% of Satellites in Orbit
March 23, 2026 By Karan Singh SpaceX has officially crossed a monumental threshold in Low Earth Orbit. As…
Promising Omani Startups Programme marks major milestone
MUSCAT: His Highness Sayyid Bilarab bin Haitham al Said, Honorary President of the ‘Programme of Promising Omani Startups’…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
Taiwan’s planned satellite cluster seen as ‘milestone’ for space capabilities
Find us on Apple Podcasts | Spotify | Amazon Music | Voicy | YouTube | YouTube Music Welcome…